ICD-10-CM Billable Code

F12.150

Cannabis abuse with psychotic disorder with delusions

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F12.150 refers to a condition where an individual abuses cannabis and develops a psychotic disorder characterized by delusions. This condition underscores the complex relationship between cannabis use and mental health, highlighting how certain substances can contribute to or trigger psychiatric symptoms. Recognizing this disorder is crucial for effective management and treatment, aiming to improve the patient's overall well-being.

Causes & Symptoms

Clinical Causes: Regular or heavy cannabis use, especially during adolescence or early adulthood. Genetic predisposition or family history of mental health disorders. Pre-existing mental health vulnerabilities that may be exacerbated by cannabis consumption. Use of high-potency cannabis products containing significant levels of THC. Environmental stressors or traumatic experiences that may interact with substance use. Personal history of or concurrent psychiatric conditions, such as schizophrenia or other psychoses.

Key Symptoms: Persistent delusions, often involving paranoia or false beliefs about persecution or conspiracy. Altered mood states, including agitation, paranoia, or suspiciousness. Hallucinations, which may involve hearing voices or visual disturbances. Disorganized thinking or difficulty concentrating. Changes in behavior such as social withdrawal or unusual conduct. Physical signs of cannabis intoxication, such as bloodshot eyes or altered reflexes. Potential deterioration in daily functioning and personal relationships. Possible worsening of underlying mental health issues.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment including a detailed patient history concerning cannabis use, psychiatric evaluation, and observation of symptoms. Healthcare professionals may utilize standardized diagnostic criteria, such as those outlined in the DSM-5, to identify the presence of psychotic symptoms alongside substance abuse. Laboratory tests or toxicology screens may be employed to confirm recent cannabis use, but diagnosis primarily relies on clinical observation and patient reports.

Treatment Protocols: Managing cannabis abuse with psychotic disorder and delusions typically involves a multidisciplinary approach, including: - **Psychotic disorder treatment:** Use of antipsychotic medications to control hallucinations and delusions. - **Substance abuse counseling:** Behavioral therapies such as cognitive-behavioral therapy (CBT) to address addiction and prevent relapse. - **Psychoeducation:** Providing information about the effects of cannabis and the importance of abstinence. - **Support systems:** Engagement with support groups and community resources to promote recovery. - **Monitoring and follow-up:** Regular psychiatric evaluations to assess progress and adjust treatments as needed. It is important to recognize that early intervention can significantly improve outcomes. Treatment plans are tailored to individual needs, considering the severity of symptoms, history of substance use, and overall mental health status.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F12.150 a billable ICD-10 code?
Yes, F12.150 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F12.150?
Clinical documentation must specify the nature of Cannabis abuse with psychotic disorder with delusions and any associated comorbidities for accurate reporting.

Cite this Clinical Reference